What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Clinical and Molecular Hepatology. 2023;29(2):332-334 
Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation
Liver Transplantation. 2005;11(S2):S45-S46
Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan
Clinical and Molecular Hepatology. 2023;29(2):352-354
The committee for revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma
Hepatology Research. 2010;40:2-3
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Clinical and Molecular Hepatology. 2023;29(2):242-251
Diagnosis and Assessment of BPH: What Should Be Done? A Glance at International Clinical Practice Guidelines
EAU Update Series. 2004;2(1):2-5
What should be done and what should be avoided when comparing two treatments?
Best Practice & Research Clinical Haematology. 2023;36(2):101473
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Clinical and Molecular Hepatology. 2023;29(2):349-351
Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe
Liver Cancer. 2015;4(2):85-95
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Journal of Liver Cancer. 2023;23(1):1-120